Brief: Tianda Pharmaceuticals expects to record decline in HY consolidated net profit
21/11/2017 04:17
Nov 21 (Reuters) - Tianda Pharmaceuticals Ltd 0455.HK :
* Expects to record a decline in HY consolidated net profit
attributable
* Expected result due to fair value gain on derecognition of
investments in redeemable convertible preference shares
Source text for Eikon: ID:nHKSTn76R
Further company coverage: 0455.HK
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Tianda Pharmaceuticals
See all newsBrief: Tianda Pharmaceuticals Says Loss Attributable Expected To Increase To Hk$61 Million For FY
Brief: Tianda Pharmaceuticals Clarifies On Fraudulent Fund Raising Scams
Brief: Tianda Pharmaceuticals Sees Loss Attributable For Interim Period Increase To Not Less Than HK$27 Mln
Brief: Tianda Pharmaceuticals Says Unit Granted Drug Registration Approval Of Ibuprofen Suspension By NMPA
Brief: Tianda Pharmaceuticals Says Drug Registration Approval Of "Nicorandil For Injection" By NMPA